Thus, Jiang and co-workers used immunohistochemistry with a triple-antibody cocktail (containing antibodies to AMACR, high molecule-weight 34βE12, and p63) to identify small, focal prostate carcinomas with high sensitivity and complete specificity [9]. This evidence concerns the gene AMACR and prostate carcinoma.